Quinlan Paul T
Reporting owner on Forms 3, 4 and 5, CIK 1333277.
Quinlan Paul T reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-20.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| ORKA · Oruka Therapeutics, Inc.CIK 907654 | officer (General Counsel) | 2 | 2026-11-20 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-20 | M exercised | +9,000 | $7.8 | 38,995 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-20 | S sold | -3,300 | $94.0485 | 35,695 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-20 | S sold | -3,000 | $94.7732 | 32,695 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-20 | S sold | -2,500 | $95.9944 | 30,195 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-20 | S sold | -200 | $96.6 | 29,995 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Employee Warrant (right to buy), derivative | 2026-11-20 | M exercised | -9,000 | $0 | 61,996 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-10-20 | M exercised | +9,000 | $7.8 | 38,995 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-10-20 | S sold | -400 | $74.9007 | 38,595 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-10-20 | S sold | -500 | $76.118 | 38,095 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-10-20 | S sold | -1,000 | $77.205 | 37,095 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-10-20 | S sold | -4,100 | $78.7895 | 32,995 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-10-20 | S sold | -3,000 | $79.4912 | 29,995 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Employee Warrant (right to buy), derivative | 2026-10-20 | M exercised | -9,000 | $0 | 70,996 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0000907654-26-000120 | Oruka Therapeutics, Inc. | 2026-11-20 | ||
| Form 4 0000907654-26-000110 | Oruka Therapeutics, Inc. | 2026-10-20 |